Skip to content
Open access · OA via Europe PMC

Interactive Pathways and Therapeutic Innovations in Elderly Sarcopenia-Diabetes Comorbidity: Breaking the Negative Self-Reinforcing Loop Through Integrated Care.

Gong F, Zhang Q, Qu R, Zhou L, Lv Y, Li J, Dai J.

Diabetes, metabolic syndrome and obesity : targets and therapy · 2026

Abstract

Against the backdrop of a rapidly aging global population, the prevalence of metabolic dysregulation and degenerative musculoskeletal conditions is escalating. Projections indicate that sarcopenia will emerge as a major public health burden over the next three decades. A robust bidirectional link connects sarcopenia with type 2 diabetes mellitus (T2DM); each condition substantially elevates the risk of the other and may accelerate functional decline and disability. Emerging data demonstrate that older adults with both T2DM and sarcopenia face a markedly higher risk of all-cause mortality than those with T2DM alone. Consequently, unraveling the shared pathophysiological underpinnings of these comorbid disorders holds profound clinical and scientific significance. We reviewed current knowledge on the interactive mechanisms driving the sarcopenia-diabetes nexus and evaluated existing therapeutic approaches through systematic searches of PubMed, Google Scholar, and Science Direct. The high co-occurrence of sarcopenia and T2DM in older adults is not coincidental; rather, it reflects a well-documented pathophysiological interrelationship. By synthesizing contemporary evidence, we aim to guide future research and refine clinical protocols designed to improve quality of life and reduce complication rates among elderly diabetic populations.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.2147/dmso.s630510
Canonical
link ↗
Fetched
2026-11-04 MST

Cite this

APA
F, G., Q, Z., R, Q., L, Z., Y, L., J, L., &amp; J., D. (2026). Interactive Pathways and Therapeutic Innovations in Elderly Sarcopenia-Diabetes Comorbidity: Breaking the Negative Self-Reinforcing Loop Through Integrated Care. <em>Diabetes, metabolic syndrome and obesity : targets and therapy</em>. https://doi.org/10.2147/dmso.s630510
Vancouver
F G, Q Z, R Q, L Z, Y L, J L, et al. Interactive Pathways and Therapeutic Innovations in Elderly Sarcopenia-Diabetes Comorbidity: Breaking the Negative Self-Reinforcing Loop Through Integrated Care. Diabetes, metabolic syndrome and obesity : targets and therapy. 2026. doi:10.2147/dmso.s630510.
BibTeX
@article{gong2026Intera, title = {Interactive Pathways and Therapeutic Innovations in Elderly Sarcopenia-Diabetes Comorbidity: Breaking the Negative Self-Reinforcing Loop Through Integrated Care.}, author = {Gong F and Zhang Q and Qu R and Zhou L and Lv Y and Li J and Dai J.}, journal = {Diabetes, metabolic syndrome and obesity : targets and therapy}, year = {2026}, doi = {10.2147/dmso.s630510}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

Wiener Medizinische Wochenschrift 2018
Citation only

Sarcopenia

▲ 102
Clinics in Geriatric Medicine 2010
Citation only

Sarcopenia

▲ 94
Clinics in Geriatric Medicine 2017
Citation only

Sarcopenia

▲ 125